Skip to main content

Table 4 Comparison of bioelectricity and HRV scores in the control group and silver needle group (mean ± SD)

From: Efficacy of silver needle therapy for the treatment of chronic nonspecific low back pain: a prospective, single-center, randomized, parallel-controlled clinical trial

  

Control group

Silver needle group

P value

Bioelectricity score

Baseline

60.6 ± 4.4

60.4 ± 3.4

0.763

3 months

86.9 ± 3.0

88.8 ± 3.3

0.007

6 months

87.3 ± 3.2

89.1 ± 2.7

0.008

InLF (In (ms2))

Baseline

4.03 ± 0.59

3.99 ± 0.66

0.738

3 months

4.70 ± 0.54

4.98 ± 0.58

0.025

6 months

4.68 ± 0.51

4.93 ± 0.62

0.047

InHF (In (ms2))

Baseline

3.42 ± 0.56

3.39 ± 0.59

0.778

3 months

4.05 ± 0.55

4.34 ± 0.54

0.019

6 months

4.06 ± 0.51

4.32 ± 0.55

0.028

LF/HF

Baseline

1.85 ± 0.27

1.84 ± 0.26

0.748

3 months

1.92 ± 0.20

1.92 ± 0.24

0.952

6 months

1.87 ± 0.23

1.87 ± 0.32

0.988

  1. HRV heart rate variability, lnLF natural logarithms of the low frequency measurement, lnHF natural logarithms of the high frequency measurement, LF/HF low frequency/high frequency ratio